Prognostic and clinical value of circPRKCI expression in diverse human cancers
Zhongyue LIU; Xiaolei REN; Zhimin YANG; Lin MEI; Wenyi LI; Chao TU; Zhihong LI.
Chinese Medical Journal
; (24): 152-161, 2024.
Artículo en Inglés | WPRIM | ID: wpr-1007681
Documentos relacionados
Prognostic role of E2F1 gene expression in human cancer: a meta-analysis.
Prognostic and clinical value of circPRKCI expression in diverse human cancers.
Evidence from a meta-analysis for the prognostic and clinicopathological importance of <i>DKC1</i> in malignancies.
Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study.
A review of linc00673 as a novel lncRNA for tumor regulation.
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
Prognostic and clinicopathological significance of GPRC5A in various cancers: A systematic review and meta-analysis.
Prognostic and clinicopathological significance of TRIM21 in various cancers: A meta and bioinformatic analysis.
Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.